Abstract:The lack of organs for transplantation is an important problem in medicine today. The growth of organs in chimeric animals may be the solution of this. The proposed technology is the interspecific blastocyst complementation method in combination with genomic editing for obtaining "free niches" and pluripotent stem cell production methods. The CRISPR/Cas9 method allows the so-called "free niches" to be obtained for blastocyst complementation. The technologies of producing induced pluripotent stem cells give us the opportunity to obtain human donor cells capable of populating a "free niche". Taken together, these technologies allow interspecific blastocyst complementation between humans and other animals, which makes it possible in the future to grow human organs for transplantations inside chimeric animals. However, in practice, in order to achieve successful interspecific blastocyst complementation, it is necessary to solve a number of problems: to improve methods for producing "chimeric competent" cells, to overcome specific interspecific barriers, to select compatible cell developmental stages for injection and the corresponding developmental stage of the host embryo, to prevent apoptosis of donor cells and to achieve effective proliferation of the human donor cells in the host animal. Also, it is very important to analyze the ethical aspects related to developing technologies of chimeric organisms with the participation of human cells. Today, many researchers are trying to solve these problems and also to establish new approaches in the creation of interspecific chimeric organisms in order to grow human organs for transplantation. In the present review we described the historical stages of the development of the blastocyst complementation method, examined in detail the technologies that underlie modern blastocyst complementation, and analyzed current progress that gives us the possibility to grow human organs in chimeric animals. We also considered the barriers and issues preventing the successful implementation of interspecific blastocyst complementation in practice, and discussed the further development of this method.

Toward developing human organs via embryo models and chimeras

Reverse Engineering the Mechanical and Molecular Pathways in Stem Cell Morphogenesis

The road to generating transplantable organs: from blastocyst complementation to interspecies chimeras

Organoid technology for tissue engineering

Synthetic Human Embryology: Towards a Quantitative Future

Stem Cell-Based Embryo Models: En Route to a Programmable Future

Xenotransplantation - a shortcut to construct tissue complexity in organoids

Towards human organ generation using interspecies blastocyst complementation: Challenges and perspectives for therapy

Modeling Human Organ Development and Diseases With Fetal Tissue-Derived Organoids

Organoid research on human early development and beyond

Editorial: Solutions for organ transplantation: Xenotransplantation and interspecies chimaeras

Reconstitution of Human Peri-Implantation Embryogenesis with Integrated Stem Cell-Based Embryo Models

Producing Human Livers From Human Stem Cells Via Blastocyst Complementation

Developing Humanized Animal Models with Transplantable Human iPSC-Derived Cells

Generation of donor organs in chimeric animals via blastocyst complementation

Hopes and Difficulties for Blastocyst Complementation

Organoids: Principle, Application and Perspective

Application of Organoids in Regenerative Medicine

Generation of human organs in pigs via interspecies blastocyst complementation

Cross-species single-cell transcriptomic analysis reveals pre-gastrulation developmental differences among pigs, monkeys, and humans

Reconstruction of structure and function in tissue engineering of solid organs: Toward simulation of natural development based on decellularization